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Abstract A structural graft often is needed to fill gaps
during reconstructive procedures of the ankle and hindfoot.
Autograft, the current gold standard, is limited in avail-
ability and configuration and is associated with donor-site
morbidity in as much as 48%, whereas the alternative
allograft carries risks of disease transmission and collapse.
Trabecular metal (tantalum), with a healing rate similar to
that of autograft, high stability, and no donor-site mor-
bidity, has been used in surgery of the hip, knee, and spine.
However, its use has not been documented in foot and
ankle surgery. We retrospectively reviewed nine patients
with complex foot and ankle arthrodeses using a tantalum
spacer. Minimum followup was 1.9 years (average,
2 years; range, 1.9–2.4 years). Bone ingrowth into the
tantalum was analyzed with micro-CT in three of the nine
patients. All arthrodeses were fused clinically and
radiographically at the 1- and 2 year followups and no
complications occurred. The American Orthopaedic Foot
and Ankle Society score increased from 32 to 74. The
micro-CT showed bony trabeculae growing onto the tan-
talum. Our data suggest tantalum may be used as a
structural graft option for ankle and subtalar arthrodesis.
All nine of our patients achieved fusion and had no com-
plications. Using tantalum obviated the need for harvesting
of the iliac spine.
Level of Evidence: Level IV, therapeutic study. See
Guidelines for Authors for a complete description of levels
of evidence.
Introduction
To achieve and maintain a desired correction, a structural
graft often is needed to fill gaps during reconstructive
procedures of the ankle and hindfoot (eg, in subtalar dis-
traction arthrodesis, fusion after failed total ankle
arthroplasty, lateral column lengthening) [50, 58]. Recog-
nized options currently include autograft, allograft, and
xenograft bone, each associated with certain disadvantages.
Autograft, which is considered the gold standard for bone
grafting because of its high healing potential, is associated
with donor-site morbidity in 15% to 48% [17, 21, 24, 38,
42, 45], postoperative complications (hematoma, hypoes-
thesia, wound dehiscence) in 3% to 39% [24, 38, 42],
limited quantity, and risk of graft collapse [24]. Allograft
and xenograft carry the risk of infectious disease trans-
mission, lower stability attributable to the preparation
process, and potential failure to integrate, which can result
in graft collapse and failure of surgery [6, 24, 35].
Porous tantalum is a trabecular metal that resembles
bone in its microstructure (Fig. 1). It is 80% porous,
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allowing two to three times greater bony ingrowth com-
pared with conventional porous coatings, and is considered
osteoconductive [3]. Its compressive strength and elastic
modulus are similar to normal bone, which theoretically
reduces stress shielding and stress concentration [3–5, 56].
Tantalum is biocompatible and its mechanical properties
have been studied extensively [2, 25, 34, 56]. Owing to its
biocompatibility, tantalum has been used safely in patients
for years for pacemaker electrodes, cranioplasty plates, and
as radiopaque markers [29, 30].
The osteointegration of tantalum was observed in a
histologic canine study [4].
Bony microstructure also has been assessed in animal
studies by micro-CT (high-resolution peripheral quantita-
tive computed tomography) [10, 52, 53]. Micro-CT has
become increasingly popular for in vivo assessment of
osteoporosis in human bone [8, 9], and we presumed it
could be used similarly with porous tantalum.
Porous tantalum has been used successfully as a struc-
tural graft for interbody cervical fusions. In two randomized
controlled trials comparing tricortical autologous iliac crest
graft and porous tantalum, similar clinical (SF-36, neck
disability index, visual analog scale) and radiographic
outcomes were found at 2 years. However, tantalum was
associated with a lower complication rate than autograft as
it avoided any donor-site morbidity [19, 54]. Tantalum also
has been used successfully in primary and revision THAs
and TKAs for reconstruction of large bony defects [20, 30,
36, 37, 40, 46, 47] and as a possible intervention for oste-
onecrosis of the femoral head [15]. Its use in the foot and
ankle is new and only one case report exists [6].
Our pilot study had two purposes: (1) to evaluate the
clinical outcome and complications after using tantalum for
ankle and subtalar arthrodesis after a short trial period;
and (2) to verify osseous incorporation of tantalum with
micro-CT.
Materials and Methods
We retrospectively reviewed nine patients with complex
foot and ankle problems who underwent arthrodesis of the
foot and ankle using a tantalum spacer (Zimmer Inc,
Warsaw, IN) from June to November 2006. There were
three men and six women, with an average age of 53 years
(range, 19–74 years). Indications included patients with
large bony defects (failed revision total ankle replacement
[one patient] [Fig. 1]), osteonecrosis of the talus in a
morbidly obese patient [one patient], subtalar nonunion in a
pantalar fusion ([one patient] in a smoker), severe flatfeet
in patients with poor bone quality (patients with rheuma-
toid arthritis with chronic prednisone use [two patients],
one of them a smoker), or with morbid obesity to increase
stability of the fusion to prevent possible collapse and loss
of correction ([four patients] Fig. 2). The mean Charlson
comorbidity score of these patients was 0.8 (range, 0–5)
[13, 18]. Minimum followup was 1.9 years (average,
2 years; range, 1.9–2.4 years). Patients provided informed
consent and the study was approved by the authors’ Uni-
versity Ethical Review Board. The study was performed in
accordance with the World Medical Declaration of
Helsinki.
Fig. 1A–B (A) Anteroposterior and (B) lateral radiographs show an
ankle fusion with a tantalum spinal fusion device after failed total
ankle arthroplasty. The 14-mm high tantalum block bridges a large
bony defect between the tibia and talus. The radiographs show signs
of bony incorporation of the tantalum and fusion of the ankle.
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The failed revision total ankle replacement was con-
verted to an ankle arthrodesis using the existing anterior
approach. After removal of the prosthesis, the tantalum
block was inserted in the bony defect. A block for spinal
surgery measuring 21 9 32 9 14 mm was used (Fig. 3A).
To maintain the position of the ankle fusion, we used two
4.5-mm tibiotalar screws (one from the lateral side intro-
duced from the posterior leg, one from the medial side
[Fig. 1]), and an external fixator from the tibia to the cal-
caneus. The external fixator was removed at 6 weeks.
The subtalar fusions were performed as part of a triple or
pantalar fusion over an extended lateral approach. After
removing the cartilage, the alignment was observed and
corrected using a lamina-spreader. It is our general practice
for patients with complex foot and ankle problems as
outlined above, to tamp a structural graft (usually allograft
from the fibula or femoral head) into the sinus tarsi similar
to a Grice-procedure [1, 7, 31, 32] to augment fixation of
the subtalar arthrodesis, thus preventing collapse and
increasing the chance of fusion. For this pilot study, we
used a tantalum block instead. Tantalum blocks are avail-
able in various shapes, sizes, and heights (Fig. 3). A trial
spacer was inserted in the sinus tarsi to determine the piece
of tantalum needed. Reshaping the tantalum with a saw is
not recommended as it seals the porous microstructure
and puts the osteoconductive properties at risk. For the
subtalar fusions, a cervical fusion device (Zimmer Inc),
14 9 14 mm (Fig. 3B) and height of 5 to 9 mm was
tamped in the sinus tarsi and the subtalar joint then was
tightened with the compression screws (Fig. 2). The sub-
talar arthrodesis was internally fixed with one to two
screws (6.5 mm screws from the heel, across the subtalar
joint, into the talus), or in patients with complex revisions
with previously fused ankles, a retrograde intramedullary
nail was inserted.
Postoperatively, all patients wore a cast and were non-
weightbearing using crutches. After 2 weeks, the sutures
were removed and the cast was changed. At 6 weeks, the
cast was exchanged, radiographs were taken, and patients
were allowed touch weightbearing. At 12 weeks, the cast
was removed and radiographs again were taken. If we
judged satisfactory union had occurred, the patient was
permitted full weightbearing or if the union was unsatis-
factory the patient was allowed partial weightbearing.
Clinical and radiographic followups were obtained at 3 to
4-week intervals until we judged the presence of union.
Radiographic criteria for fusions were complete bridging of
the joint line/osteotomy site by trabeculae and absence of a
visible joint line or gap. The treating surgeons (HD, IR) and
the hospital radiologist independently determined the
occurrence of fusion radiographically, or with CT if needed.
After the fusion had been verified, all patients were
followed clinically and radiographically during the post-
operative course with radiographs 1 and 2 years
postoperatively and with further clinic visits if indicated by
problems. At the 2-year followup, the AOFAS score [26]
was assessed by the treating physician. Main outcome
measurements were the clinical outcome (fusion rate) and
complications in the 2-year period.
To assess the microanatomy, we obtained micro-CT
scans (Scanco Medical, Bru¨ttisellen, Switzerland) at the
2-year followup, but owing to artifacts from previous
hardware [28, 51], it was limited to use in patients with
fewer than three screws and a distance greater than 1 cm
between tantalum and screws. Four of the nine patients
qualified, but one declined to participate in the study,
which resulted in three micro-CT scans. We used 60 kVp,
1000 lamp, 100-millisecond integration time for each
micro-CT scan. The total time for each measurement was
approximately 4 minutes and resulted in 150 slices or a
12-mm-long three-dimensional representation of the foot.
The effective radiation dose from one scan was approxi-
mately 4 lSv, which was well below the recommended
annual dose limit (approximately 1 mSv) for the general
Fig. 2A–C (A) Anteroposterior,
(B) dorsoplantar, and (C) lateral
radiographs show a patient after
triple-realignment arthrodesis
using a tantalum cervical fusion
device. The tantalum block was
tamped into the sinus tarsi to
achieve and maintain the desired
correction. The radiographs show
signs of bony incorporation of the
tantalum and fusion of the subta-
lar joint.
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public (International Commission on Radiological Protec-
tion) [23].
Results
At 1 and 2 years followup, all nine arthrodeses were fused.
We observed no patients with collapse, loss of correction,
or infection. The AOFAS score increased from 32 (range,
8–62) preoperatively to 74 (range, 37–100) at the 2-year
followup.
In the three patients with micro-CT, we observed con-
densation of bony trabeculae on the tantalum (Fig. 4) with
bone ingrowth in the bone-implant interface. Bone
ingrowth in the tantalum could not be evaluated owing to
artifacts of the metal.
Discussion
Tantalum has been used successfully in cervical interbody
fusions and primary and revision total hip and knee
replacements [19, 20, 30, 36, 37, 40, 46, 47, 54]. Its use in
foot and ankle surgery has not been documented. We
therefore evaluated the clinical scores and complications
after using tantalum for ankle and subtalar arthrodesis after
a 2-year period. As the use of tantalum is new in foot and
ankle surgery, we questioned whether osseous incorpora-
tion of tantalum could be verified with micro-CT. The
second purpose of our pilot study, therefore, was to
investigate osseous incorporation of tantalum in vivo using
micro-CT.
Our pilot study has certain limitations. First, the number
of patients was small and conclusions comparing tantalum
with autograft or allograft are not possible. A randomized
controlled prospective trial would be needed [19, 54]. A
larger series of 50 to 100 patients originally was planned
with approval from the authors’ local institution, but our
plans subsequently were modified by the Provincial Health
Technology Assessment Committee to include a limited
number of patients who would be reviewed after a short
Fig. 3A–B The photographs show (A) a tantalum spinal fusion
device used as a spacer for ankle fusion after failed total ankle
arthroplasty and (B) a cervical fusion device used as a spacer for
subtalar arthrodesis. After using a trial spacer in the operation, a
tantalum block can be selected from various shapes, sizes, and heights
to achieve the most optimal fit. Tantalum should not be cut with a saw
as this would seal its porous microstructure and jeopardize its
osteoconductive properties.
Fig. 4A–B (A) A sagittal view micro-CT shows condensation of
trabeculae on the tantalum block, which means the force transmission
from the tibia to the talus flows through the tantalum block. (B) A
frontal view micro-CT shows ingrowth of trabeculae on the porous
structure of the tantalum. Artifacts in the tantalum make interpretation
of bony ingrowth in the tantalum impossible.
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trial period before exposing more patients, despite the fact
that porous tantalum already was used in spinal surgery. A
similar situation was reported by Wigfield et al. when
starting to use tantalum in spine surgery [54]. Second, the
imaging of tantalum by CT or micro-CT is associated with
artifacts in the tantalum and in the direction of the xray
beam [28, 51]. When the bone-tantalum interface was
parallel to the xray beam, artifacts were minimal. However,
other hardware such as screws, plates, or intramedullary
nails in the region of the tantalum created artifacts which
made precise assessment of bone ingrowth impossible in
most of these patients with complicated foot problems.
Third, we do not know the long-term outcome of these
procedures and whether long-term complications would
develop, or the difficulties in revising these procedures (eg,
in case of secondary infection) should that be necessary.
All of the hindfeet or ankles of our nine patients with
porous tantalum have fused and we observed no compli-
cations. These observations are consistent with those
reported with the use of tantalum in spinal fusion and
treatment of bony defects in revision and primary THAs
and TKAs [30, 36, 40, 47]. Tantalum has the advantage
that it avoids donor-site morbidity of harvesting the iliac
crest graft and the possibility of disease transmission.
Harvesting autograft at the iliac crest has a reported donor-
site morbidity rate of 15% to 48% (postoperative hema-
toma, infection, hypesthesia, increased postoperative pain,
wound dehiscence, cosmetic defect, prolonged pain in the
long term, and impairment in ambulation, work, and
activities of daily living [17, 21, 24, 38, 42]). The cost of
tantalum (approximately $1000 per block in the US)
is comparable to allograft ($850, plus approximately
Table 1. Summary of advantages and disadvantages of structural graft options reported in the literature
Graft option Stability Healing potential Disadvantages Advantages Quantity Costs
Autograft Gold standard Gold standard Donor-site morbidity up
to 48%, postoperative
complications up to
39%, possible
collapse [17, 21, 24,
38, 42, 44, 45]
Best healing
potential
Limited Approximately 20
minutes OR
(approximately
$600–$700)
Allograft Less owing to the
preparation
process [19,
24, 54]
Less [33, 41, 47,
48]
Possible infectious
disease transmission,
possible collapse [33,
41, 55]
No donor-site
morbidity
Limited Approximately $850
Tantalum Similar to normal
bone [3, 4, 56]
Similar to gold
standard [19,
54]
Difficult radiographic
assessment of fusion
[28, 51, 54]
No donor-site
morbidity, no
reported
complications
[19, 20, 36, 37,
54]
Unlimited Approximately
$1000 per piece
Table 2. Possible operations for management of a failed total ankle replacement
Study (year) Followup
(years)
Operation Graft Fusion rate
(n/n)
Graft/operation-related
complications
Thomason and Eyres
(2008) [49]
2.7 Intramedullary nail Femoral head allograft 3 of 3 None reported
Carlsson (2008) [11] 1.6 Intramedullary nail Titanium cage with
autograft
0 of 3 Subtalar joint sacrificed,
all nonunions
Schill (2007) [43] 1–3 Intramedullary nail Autograft from fibula
or iliac crest
14 of 15 None reported
Culpan et al. (2007) [16] 3.7 Compression screws Iliac crest autograft 15 of 16 None reported
Kotnis et al. (2006) [27] 1 Intramedullary nail No 9 of 9 None reported
Hopgood et al. (2006) [22] 2.4 Intramedullary nail
or compression screws
No 17 of 23 None reported
Zwipp and Grass (2005) [57] 1 Compression screws
and plates
Iliac crest autograft 3 of 4 None reported
Carlsson et al. (1998) [12] 4–15 External fixation No 17 of 21 None reported
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5 minutes of preparation time in the operating theater) or
harvesting iliac crest autograft (estimated at $600 to $700,
as it involves approximately 20 minutes of operating time,
suture material, sponges, and dressing) (Table 1).
The treatment of a failed total ankle replacement is
challenging with only a few reports of outcomes (Table 2).
Ankle arthrodesis without structural grafting results in
considerable shortening of the leg, donor-site morbidity
with the use of autograft, and intramedullary nailing sac-
rifices the subtalar joint (Table 2). Using a porous tantalum
block in conjunction with external fixation could avoid
these problems. It is our general practice to augment sub-
talar fusions in patients with complex foot and ankle
problems with a structural graft (usually allograft) tamped
into the sinus tarsi similar to a Grice-procedure [1, 7, 31,
32]. For this pilot study, a block of tantalum was used
instead. Other studies using structural grafts in foot surgery
are limited to autograft from the fibula or iliac crest with a
union rate of 87% to 100% (Table 3) [1, 7, 14, 31, 32, 39,
50]. Donor-site morbidity was not reported in these studies,
but we presume the rates would be similar to those reported
for spinal surgery.
We observed condensation of trabeculae in the tantalum
block in three of our nine patients. However, owing to
artifacts from surrounding hardware in many patients, we
believe micro-CT generally is not suitable to assess osse-
ous integration of tantalum.
Our data suggest porous tantalum may be used as a
structural graft for ankle and subtalar arthrodesis. All nine
of our patients achieved fusion without any complications,
corresponding to the findings reported when tantalum has
been used in spine and primary and revision total hip and
knee replacements. Harvesting of graft from the iliac spine
was not necessary, thus eliminating donor-site morbidity.
We believe tantalum is useful in complex cases such as
revisions when a high healing potential is desired to
achieve fusion or in morbidly obese patients when a graft
with greater stability is required.
Acknowledgments We thank Dr. Iain Russell for following and
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